Skip to main content
  • Preoperative Particle and Glue Embolisation of Meningiomas: Indications, results and lessons learnt from 117 consecutive patients

    Final Number:
    1302

    Authors:
    jinendra ekanayake MBBS BSc MRCS; Anouk Borg MD MSc; Richard Mair MB ChB MRCS; Stefan Brew MB ChB MHB(Sci) MSc FRANZCR; Fergus Robertson MRCP FRCR; Neil Kitchen MD, FRCS; George Samandouras MD FRCS (SN)

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: Preoperative embolization of meningiomas remains an enduringly controversial topic in intracranial surgery. The benefit of post-embolization reduction in intraoperative blood loss must be counterbalanced against increased hospital stay, and potential embolic complications. We attempted to examine the safety and efficacy of pre-operative embolization in a series of 117 patients who underwent either glue or particle embolization. Factors assessed included (i) selection of embolic agent (ii) type of complication associated with embolic agent (iii) intraoperative blood loss(iv) extent of surgical resection.

    Methods: Retrospective review of 117 consecutive patients between 2001- 2010 undergoing pre-operative embolization prior to surgery for intracranial meningiomas. Imaging studies, operative reports, anaesthetic charts, and histology reports were examined for patient demographics, tumour size, location and vascular supply, as well procedural details including arterial territories targeted, embolic agent, degree of devascularisation, transfusion requirements and complications.

    Results: 107 patients underwent embolization under two operators (10 cases were abandoned). Mean blood transfusion requirement during surgery was 0.8 units per case (range 1-14 units). Blood transfusion was significantly lower in patients whose meningiomas were completely devascularized (P=0.35). The degree of devascularisation achieved (total or partial)(p = 0.76), and blood transfusion requirement (p = 0.29), did not vary significantly in relation to embolic materials. Four patients (3.7%) had neurological complications: 2 haemorrhagic, 1 ischaemic, 1 cranial nerve palsy.

    Conclusions: The complication rate at our institution was 3.7%. No relationship between embolic agent and degree of devascularization was observed. Glue embolisation enabled a more tailored approach with regards to individual vessel morphology due to increased control over its delivery, and was used when surgical expedience was required. Complete devascularization resulted in lower blood transfusion requirements. This study demonstrates pre-operative embolization with glue and particle agents is a safe, useful adjunct in the neurosurgical management of intracranial meningiomas. A large scale randomised controlled trial is warranted.

    Patient Care: Improved awareness and understanding of a useful pre-operative procedure which may enable safer neurosurgery of intracranial meningiomas

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Consider the role and usefulness of pre-operative embolisation for intracranial meningiomas 2) Discuss the indications, benefits and risks of pre-operative embolisation of intracranial meningiomas 3) Describe the relative advantages and disadvantages of glue and particle embolisation

    References: Bendszus M. Is there a benefit of preoperative meningioma embolization? Neurosurgery 2001;47:1306-1311 Simonetti L, Raffi L, Cenni P, Andreoli A, Calbucci F, Leonardi M. Presurgical embolization of intracranial extra-axial tumours using Glubran 2®: Our experience in 14 patients. Rivista di Neuroradiologia 2004;17:645-658 Carli DFM, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR, American journal of neuroradiology 2010;31:152-154

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy